問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2023-01-05 - 2026-12-31
Condition/Disease
Test Drug
Participate Sites4Sites
Recruiting4Sites
2023-08-01 - 2029-01-17
Untreated T4N0 or stage III mismatch repair-deficient (dMMR)/microsatellite instability-high (MSI-H) resectable colon cancer
JEMPERLI 500 mg concentrate for solution for infusion
Not yet recruiting1Sites
Recruiting3Sites
2022-01-01 - 2025-12-31
Participate Sites6Sites
Terminated2Sites
2021-12-31 - 2025-10-01
Participate Sites5Sites
Recruiting5Sites
2009-02-01 - 2013-02-01
Participate Sites7Sites
Terminated7Sites
2010-08-16 - 2014-12-31
Terminated6Sites
2012-01-01 - 2014-12-31
Terminated5Sites
2021-12-01 - 2024-12-31
Participate Sites3Sites
Terminated3Sites
2007-10-01 - 2009-09-30
2005-10-01 - 2008-07-01
Participate Sites10Sites
Terminated10Sites
全部
